Clinical relevance of thymidylate synthase expression in the signet ring cell histotype component of colorectal carcinoma

被引:11
作者
Cabibi, D
Calascibetta, A
Campione, M
Barresi, E
Rausa, L
Dardanoni, G
Aragona, F
Sanguedolce, R
机构
[1] Policlin Palermo, Dipartimento Sci Farmacol, I-90100 Palermo, Italy
[2] Ist Anat Patol, I-90100 Palermo, Italy
[3] Fac Med & Chirurg, Dipartimento Oncol Sperimentale & Applicaz Clin, I-90100 Palermo, Italy
[4] Osservatorio Epidemiol Reg Sicilia, I-90100 Palermo, Italy
关键词
thymidylate synthase expression; signet ring cell carcinoma; colorectal carcinoma; immunohistochemistry;
D O I
10.1016/j.ejca.2004.07.034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thymidylate Synthase (TS) is the key enzyme for DNA synthesis pathways and is inhibited by 5-Fluorouracil (5FU). The aim of this work was to study TS expression and the proliferation rate in the different histological types of colorectal carcinoma (CRC). 50 patients with CRC were included in this study and evaluated immunoltistochemically using the monoclonal antibodies, TS106 and Ki67. 20 tumours were of the intestinal type, 15 cases were signet ring cell carcinoma (SRCCs) and 15 cases were "mixed-type", with at least two different histological components. Intestinal and mucinous histotypes were positive for TS and Ki67, while "signet ring cell" samples were negative or showed only weak and focal positivity for both the TS and Ki67 antibodies. Our results show that signet ring cells (that are also often present in intestinal and mucinous carcinomas), are in the post-mitotic phase of the cell cycle and show a low proliferation index and TS expression. As TS is the key enzyme for DNA synthesis pathways and is inhibited by 5-fluorouracil (5FU), we can hypothesise that TS expression levels in the different histotypes of CRC could affect the potential responsiveness of these tumours to fluoropyrimidine chemotherapy, with a low efficacy being expected in signet ring cell areas. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2845 / 2850
页数:6
相关论文
共 28 条
[1]  
Araki Yasumi, 2001, Kurume Medical Journal, V48, P93
[2]   Thymidylate Synthase expression as a predictor of clinical response to fluoropyrimidine-based chemotherapy in advanced colorectal cancer [J].
Aschele, C ;
Lonardi, S ;
Monfardini, S .
CANCER TREATMENT REVIEWS, 2002, 28 (01) :27-47
[3]   Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer [J].
Backus, HHJ ;
van Riel, JMGH ;
van Groeningen, CJ ;
Vos, W ;
Dukers, DF ;
Bloemena, E ;
Wouters, D ;
Pinedo, HM ;
Peters, GJ .
ANNALS OF ONCOLOGY, 2001, 12 (06) :779-785
[4]  
Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979
[5]   Thymidylate synthase expression in colorectal cancer:: A prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy [J].
Edler, D ;
Glimelius, B ;
Hallström, M ;
Jakobsen, A ;
Johnston, PG ;
Magnusson, I ;
Ragnhammar, P ;
Blomgren, H .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) :1721-1728
[6]   Immunohistochemical determination of thymidylate synthase in colorectal cancer - methodological studies [J].
Edler, D ;
Blomgren, H ;
Allegra, CJ ;
Johnston, PG ;
Lagerstedt, U ;
Magnusson, I ;
Ragnhammar, P .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (13) :2278-2281
[7]  
Edler D, 2000, CLIN CANCER RES, V6, P1378
[8]  
Edler D, 2000, CLIN CANCER RES, V6, P488
[9]  
Foekens JA, 2001, CANCER RES, V61, P1421
[10]  
Grem JL, 2001, CLIN CANCER RES, V7, P999